Document is current
Any future updates will be listed below
-
Authors
Schertzer, Megan D.
Park, Stella H.
Su, Jiayu
Reese, Fairlie
Sheynkman, Gloria M.
Knowles, David A.
-
Funding
Funding for this research was provided by:
NIH/NIGMS (F32GM142213)
Columbia University Fu Foundation School of Engineering and Applied Science Bonomi Scholarship
Columbia University Scholars Program Summer Enhancement Fellowship
NIH/NCI (R33CA281919)
NIH/NCI (R21CA272345)
MacMillan Center for the Study of the Non-Coding Cancer Genome
- License Information
-
More Information
Article History
Received: 3 October 2025
Accepted: 25 August 2026
First Online: 2 September 2026
Declarations
Ethics approval and consent to participate: Not applicable.
Consent for publication: Not applicable.
Competing interests: G.M.S. is on the scientific advisory board of Quantum-Si Incorporated and holds stock in Quantum-Si Incorporated. G.M.S. and D.A.K. are scientific cofounders at NeoSplice Therapeutics. The remaining authors declare no conflicts of interest.
